Latest filings (excl ownership)
10-Q
2024 Q2
Quarterly report
1 Aug 24
8-K
NextCure Provides Business Update and Reports Second Quarter 2024 Financial Results
1 Aug 24
8-K
Submission of Matters to a Vote of Security Holders
21 Jun 24
8-K
Departure of Directors or Certain Officers
18 Jun 24
10-Q
2024 Q1
Quarterly report
2 May 24
8-K
NextCure Provides Business Update and Reports First Quarter 2024 Financial Results
2 May 24
DEFA14A
Additional proxy soliciting materials
26 Apr 24
DEF 14A
Definitive proxy
26 Apr 24
PRE 14A
Preliminary proxy
16 Apr 24
10-K
2023 FY
Annual report
21 Mar 24
8-K
NextCure Provides Business Update and Reports Full Year 2023 Financial Results
21 Mar 24
8-K
NextCure Provides Year-End Clinical Pipeline Updates
14 Dec 23
10-Q
2023 Q3
Quarterly report
2 Nov 23
8-K
NextCure Provides Business Update and Reports Third Quarter 2023 Financial Results
2 Nov 23
EFFECT
Notice of effectiveness
14 Aug 23
CORRESP
Correspondence with SEC
9 Aug 23
UPLOAD
Letter from SEC
8 Aug 23
S-8
Registration of securities for employees
4 Aug 23
S-3
Shelf registration
4 Aug 23
10-Q
2023 Q2
Quarterly report
3 Aug 23
8-K
NextCure Provides Business Update and Reports Second Quarter 2023 Financial Results
3 Aug 23
8-K
Departure of Directors or Certain Officers
19 Jul 23
8-K
Amendments to Articles of Incorporation or Bylaws
26 Jun 23
10-Q
2023 Q1
Quarterly report
4 May 23
8-K
NextCure Provides Business Update and Reports First Quarter 2023 Financial Results
4 May 23
ARS
2022 FY
Annual report to shareholders
28 Apr 23
DEFA14A
Additional proxy soliciting materials
28 Apr 23
DEF 14A
Definitive proxy
28 Apr 23
424B5
Prospectus supplement for primary offering
3 Apr 23
10-K
2022 FY
Annual report
2 Mar 23
8-K
NextCure Provides Business Update and Reports Full Year 2022 Financial Results
2 Mar 23
10-Q
2022 Q3
Quarterly report
3 Nov 22
8-K
NextCure Provides Update and Reports Third Quarter 2022 Financial Results
3 Nov 22
10-Q
2022 Q2
Quarterly report
4 Aug 22
8-K
NextCure Provides Business Update and Reports Second Quarter 2022
4 Aug 22
8-K
Submission of Matters to a Vote of Security Holders
23 Jun 22
10-Q
2022 Q1
Quarterly report
5 May 22
8-K
NextCure Provides Business Update and Reports First Quarter 2022 Financial Results
5 May 22
DEF 14A
Definitive proxy
29 Apr 22
DEFA14A
Additional proxy soliciting materials
29 Apr 22
Latest ownership filings
SC 13G
Affinity Asset Advisors, LLC
27 Jun 24
4
Stephen W Webster
21 Jun 24
4
DAVID S KABAKOFF
21 Jun 24
4
Elaine V Jones
21 Jun 24
4
John G Houston
21 Jun 24
4
Ellen Feigal
21 Jun 24
4
Anne Elizabeth Borgman
21 Jun 24
4
Kevin G. Shaw
2 Apr 24
4
Michael Richman
2 Apr 24
4
Han Myint
2 Apr 24
4
Timothy Mayer
2 Apr 24
4
Sol Langermann
2 Apr 24
4
Sourav Kundu
2 Apr 24
4
Steven P. Cobourn
2 Apr 24
SC 13G
Logos Global Management LP
1 Apr 24
SC 13D/A
ORBIMED ADVISORS LLC
8 Mar 24
4
Kevin G. Shaw
1 Feb 24
4
Michael Richman
1 Feb 24
4
Han Myint
1 Feb 24
4
Timothy Mayer
1 Feb 24
4
Sol Langermann
1 Feb 24
4
Sourav Kundu
1 Feb 24
4
Steven P. Cobourn
1 Feb 24
SC 13G/A
MILLENNIUM MANAGEMENT LLC
19 Jan 24
4
Garry A Nicholson
23 Jun 23
4
DAVID S KABAKOFF
23 Jun 23
4
Chau Quang Khuong
23 Jun 23
4
John G Houston
23 Jun 23
4
Ellen Feigal
23 Jun 23
4
Elaine V Jones
23 Jun 23
4
Stephen W Webster
23 Jun 23
4
Anne Elizabeth Borgman
23 Jun 23
4
Timothy Mayer
1 Mar 23
4
Sourav Kundu
1 Mar 23
4
Han Myint
1 Mar 23
4
Kevin G. Shaw
1 Mar 23
4
Sol Langermann
1 Mar 23
4
Michael Richman
1 Mar 23
4
Steven P. Cobourn
1 Mar 23
3
Kevin G. Shaw
28 Feb 23